Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment and comparison of viability assays for cellular products.
Cai Y, Prochazkova M, Kim YS, Jiang C, Ma J, Moses L, Martin K, Pham V, Zhang N, Highfill SL, Somerville RP, Stroncek DF, Jin P. Cai Y, et al. Among authors: moses l. Cytotherapy. 2024 Feb;26(2):201-209. doi: 10.1016/j.jcyt.2023.11.008. Epub 2023 Dec 11. Cytotherapy. 2024. PMID: 38085197 Free article.
High efficiency closed-system gene transfer using automated spinoculation.
Remley VA, Jin J, Sarkar S, Moses L, Prochazkova M, Cai Y, Shao L, Liu H, Fuksenko T, Jin P, Stroncek DF, Highfill SL. Remley VA, et al. Among authors: moses l. J Transl Med. 2021 Nov 24;19(1):474. doi: 10.1186/s12967-021-03126-4. J Transl Med. 2021. PMID: 34819105 Free PMC article.
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.
Tian M, Wei JS, Shivaprasad N, Highfill SL, Gryder BE, Milewski D, Brown GT, Moses L, Song H, Wu JT, Azorsa P, Kumar J, Schneider D, Chou HC, Song YK, Rahmy A, Masih KE, Kim YY, Belyea B, Linardic CM, Dropulic B, Sullivan PM, Sorensen PH, Dimitrov DS, Maris JM, Mackall CL, Orentas RJ, Cheuk AT, Khan J. Tian M, et al. Among authors: moses l. Cell Rep Med. 2023 Oct 17;4(10):101212. doi: 10.1016/j.xcrm.2023.101212. Epub 2023 Sep 28. Cell Rep Med. 2023. PMID: 37774704 Free PMC article.
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.
Tian M, Wei JS, Shivaprasad N, Highfill SL, Gryder BE, Milewski D, Brown GT, Moses L, Song H, Wu JT, Azorsa P, Kumar J, Schneider D, Chou HC, Song YK, Rahmy A, Masih KE, Kim YY, Belyea B, Linardic CM, Dropulic B, Sullivan PM, Sorensen PH, Dimitrov DS, Maris JM, Mackall CL, Orentas RJ, Cheuk AT, Khan J. Tian M, et al. Among authors: moses l. Cell Rep Med. 2024 May 21;5(5):101586. doi: 10.1016/j.xcrm.2024.101586. Epub 2024 May 9. Cell Rep Med. 2024. PMID: 38723625 No abstract available.
The impact of package selection and versioning on single-cell RNA-seq analysis.
Rich JM, Moses L, Einarsson PH, Jackson K, Luebbert L, Booeshaghi AS, Antonsson S, Sullivan DK, Bray N, Melsted P, Pachter L. Rich JM, et al. Among authors: moses l. bioRxiv [Preprint]. 2024 Apr 11:2024.04.04.588111. doi: 10.1101/2024.04.04.588111. bioRxiv. 2024. PMID: 38617255 Free PMC article. Preprint.
A Preliminary Validation of an Optimal Cutpoint in Total Number of Patient-Reported Symptoms in Head and Neck Cancer for Effective Alignment of Clinical Resources with Patients' Symptom Burden.
Van Cleave JH, Concert C, Kamberi M, Zahriah E, Most A, Mojica J, Riccobene A, Russo N, Liang E, Hu KS, Jacobson AS, Li Z, Moses LE, Persky MJ, Persky MS, Tran T, Brody AA, Kim A, Egleston BL. Van Cleave JH, et al. Among authors: moses le. Cancer Care Res Online. 2024 Jan;4(1):e051. doi: 10.1097/cr9.0000000000000051. Epub 2023 Nov 22. Cancer Care Res Online. 2024. PMID: 38586274
241 results